Myocarditis is recognized as a rare but serious adverse reaction to messenger RNA (mRNA) vaccination against COVID-19.

The updated 2024-2025 mRNA COVID vaccine from Moderna does not appear to carry the same risk for myocarditis in young adults that the first mRNA COVID vaccines did, suggested research presented at the ...

Patients who develop myocarditis within the first month of receiving immune checkpoint inhibitor therapy are more likely to have MC fatality.

One of the most widely known risks linked to the COVID-19 vaccine is myocarditis, especially in young males — and now a new Stanford study has shed some light on why this rare effect can occur.

Recommendations in the new ESC guidelines are largely consistent with those of the 2024 American College of Cardiology (ACC) expert consensus decision pathway on managing myocarditis, and a 2025 joint ...

Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely ...

Mikey Moore is having himself a heck of a season on loan at Rangers. The 18-year-old Tottenham Hotspur winger is flying at ...

Early myocarditis onset may predict treatment-related fatality in patients receiving immune checkpoint inhibitor therapy.